Guillain-Barré syndrome in older adults following vaccination against respiratory syncytial virus: MHRA drug safety update
Posted 9 Jan 2026
Dr Lisa Devine summarises a recent drug safety update from the MHRA regarding possible risks of Guillain-Barré syndrome in people vaccinated against respiratory syncytial virus, including practice points on identifying the condition.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page